晨间信号Morning Signal
《新科学家》 第3608期 · 2026年8月15日 · 中文解读

问题肽类

Problematic peptides · Grace Wade
约 6 分钟Views Columnist在小程序里点播,20 到 60 分钟做好
这篇讲什么
美国药物咨询委员会建议批准几种实验性肽类药物,这给人们留下了其有效性的错误印象。
原文开头
Problematic peptides A US drug advisory committee has recommended approval for several experimental peptides. This gives the wrong impression of their effectiveness, says Grace Wade PEPTIDES are everywhere, so much so that wellness spas, massage parlours, chiropractor offices and rehabilitation clinics, particularly in the US but also elsewhere, are offering peptide injections. Proponents claim they can help combat ageing, heal injuries, dampen inflammation, accelerate weight loss and treat a seemingly endless list of conditions. There is little robust evidence to back up these claims, but that hasn’t stemmed people’s enthusiasm. Estimates suggest the unregulated market for peptides is a $100 million to $3 billion industry. Put simply, peptides are small proteins. …
摘自《新科学家》(New Scientist)第3608期 · 2026年8月15日,Grace Wade。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章